HIF1A and neoplasm: To facilitate comparability of results and expedite the identification of candidates for clinical translation, we recommend a minimum reporting standard including pO2 pre- and post-therapy measurements, quantification of HIF-1α expression, quantification of ROS, measures of efficacy (e.g., % inhibition or tumor regression), and complete biodistribution and toxicology data.